BDTX

BLACK DIAMOND THERAPEUTICS I

BDTX·09203E105·US·Common Stock·Healthcare - Biotechnology-13D/G

BDTX (BLACK DIAMOND THERAPEUTICS I) is held by 67 institutional investors as of Q2 2026. Largest holders: BlackRock, Inc. ($7.2M), VANGUARD CAPITAL MANAGEMENT LLC ($3.9M), RENAISSANCE TECHNOLOGIES LLC ($3.6M). Net institutional sentiment: Mixed.

67
Holders
(2 Elite)
$36.5M
Total Value
59% (74)
Consensus
44 buying - 30 selling
13F: Insider & Congress: Updated regularly
BDTX

Smart Money Verdict

View all
Loading verdict
Held by 67 funds
2 elite

Who's Trading

Source dates: Price Aug 27, 2026 · Insiders Mar 20, 2025 · Activists Jul 27, 2026 · Congress none

ActivistBlackRock, Inc.BlackRock, Inc.6.7%Jul 27, 2026
ActivistTRT. Rowe Price Investment Management, Inc.7.0%Jul 8, 2026
ActivistVPVestal Point Capital, LP1.5%Feb 17, 2026
Checking access…

Top Holders

Checking access…
Fund
Action
Shares
Value
Weight
Est. P&L
Conviction
Increased
3.9M(+253.9%)$7.2M0.0%+16.82%
44
Increased
2.1M(+14.8%)$3.9M0.0%+1.26%
31
Increased
2M(+19.4%)$3.6M0.0%-12.52%
31
Increased
1.4M(+4.9%)$2.5M0.0%-8.70%
27
Increased
1.2M(+127.0%)$2.3M0.0%-53.09%
42
Increased
1.1M(+3.3%)$2M0.0%-10.95%
27
Increased
896,602(+7.2%)$1.7M0.0%-20.97%
28
Increased
643,668(+3.2%)$1.2M0.0%+2.83%
26
Increased
542,172(+6.1%)$1M0.0%-0.18%
27
Increased
525,013(+145.9%)$971,2740.0%-18.49%
27
Increased
413,516(+262.3%)$765,0040.0%+13.93%
27
Increased
407,074(+336.9%)$753,0870.0%+16.23%
27
Decreased
365,394(-21.4%)$675,9790.0%-48.42%
0
Increased
318,763(+68.5%)$589,7130.0%-15.45%
36
Increased
309,853(+19.2%)$573,2280.0%+1.91%
29
New
295,172$546,0680.0%+22.70%
34
Increased
289,712(+205.5%)$535,9670.0%+10.10%
27
Increased
288,871(+58.5%)$534,4110.0%-11.61%
35
Decreased
288,780(-57.8%)$534,2430.0%-5.15%
0
Increased
281,245(+0.9%)$520,3040.0%-19.51%
24

Showing 1-20 of 81

1 / 5
BDTXBDTXBLACK DIAMOND THERAPEUTICS I

Other Healthcare stocks held by institutions

Data sourced from four public-disclosure sources: SEC 13F, Form 4, 13D/13G, and House/Senate STOCK Act disclosures. Not financial advice. Full disclaimer

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used